The Long and Winding Road of HIV Complications: Aging with HIV Luis A. Espinoza, MD Associate Professor of Clinical Medicine University of Miami Miller School of Medicine Faculty, Florida/Caribbean AETC
Apr 02, 2015
The Long and Winding Road of HIV
Complications: Aging with HIV
Luis A. Espinoza, MDAssociate Professor of Clinical Medicine
University of Miami Miller School of Medicine
Faculty, Florida/Caribbean AETC
Disclosure of Financial Relationships
This speaker has the following financial relationships with commercial entities to
disclose:• Consultant: Gilead, Tibotec, ViiV – Terminated
• Speaker’s Bureau: Abbott, Boehringer, Gilead, Tibotec – Terminated
This speaker will not discuss any off-label use or investigational product during the program.
This slide set has been peer-reviewed to ensure that there are no conflicts of interest represented in the presentation.
HIV and Aging
Objectives• Discuss the evolving complications being
seen in the aging HIV population• Improve patient education in reduction of
risk factors in disease seen in the aging population
• Implement appropriate recommendations in screening and monitoring in the aging HIV population
As estimated by the CDC: The percentage of HIV infected individuals older than 50 years, in the year 2015 will be:
A. 20%
B. 25%
C. 30%
D. 40%
E. > 50%
A. B. C. D. E.
0%
13%
45%
32%
10%
Prevalence of HIV Infection in US
From: www.cdc.gov/hiv/topics/over50
Estimated Percentage of New Cases of HIV/AIDS by Age, 2005
From: www.cdc.gov/hiv/topics/over50
Aging and Comorbidities
• Common disorders in older adults– Cardiovascular disease– Hypertension– Metabolic disorders, obesity– Neurocognitive decline– Hepatic and/or renal impairment– Bone fractures/Osteopenia/osteoporosis– Malignancies
Biology of Aging in Humans
Vijg and Campisi, Nature 2008
Telomeres and
TelomeraseAppendix C: Human
Embryonic Stem Cells and Human Embryonic Germ
Cells . In Stem Cell Information. Bethesda,
MD: NIH US DHHS, 2010
Telomeres and Telomerase
Human Telomeric and Subtelomeric Regions
http://AtlasGeneticsOncology.org/Deep/SubTelomereID20025.html June 2009
Telomeres, senescence and organismal aging
http://AtlasGeneticsOncology.org/Deep/SubTelomereID20025.html June 2009
Haematopoietic stem cells experience functional decline with aging
Sahin and DePinho, Nature 2010
Aging of the Immune System “Immunosenescence”
T cell characteristics that predict morbidity/mortality in the very old:
• Reduced regenerative capacity (stem cells, thymus)• Low naïve/memory T cell ratios• Low CD4/CD8 ratio• Increased T cell activation• Increased inflammatory markers (IL-6, CRP)• Clonal expression of CD28-CD57+ T cells• Expanded CMV specific T cell responses• Reduced T cell proliferation
Weng N. Immunity, 2006;24:495-499
Cao W. JAIDS 2009; 50:137-147
Linton PJ. Nat Immunol. 2004; 2:133-139
Barrier to HIV Diagnosis in Older Adult
• Physicians are less likely to discuss HIV related risk factors with older adults
• HIV-associated symptoms and other illnesses
• Late presentation for diagnosis and care• CDC recommendations
Patel D. Curr Inf Dis Rep 2011 Gebo KA. Drugs Aging 2006
Lindau ST. NEJM 2007 MMWR Recomm Rep 2006
Risk for Older HIV-Uninfected Adults
• National Survey of Sexual Health and Behavior (2008)
Among all persons aged 50 years or older, condoms were not used during most recent intercourse with:
91.5% of casual partners
76.0% of friends
69.6% of new acquaintances
33.3% of transactional sexual partners
Schick V et al. J Sex Med. 2010;7(Suppl 5):315-329
Issues Specific toOlder Persons With HIV Disease
• Unprotected sex– No concern about pregnancy– “I’m too old to catch HIV”
• Delay in testing• Limited incomes• Immune restoration • Comorbid illnesses• Polypharmacy• Insufficient data on drug interactions in older
population
Luther VP, et al. Clin Geriatr Med. 2007;23:567-583.Illa L, et al. AIDS Behav. 2008;12:935-942.
NIH Statement on National HIV/AIDS and Aging Awareness Day - September 18, 2010
“Older HIV-infected adults face unique health challenges stemming from age-related changes to the body accelerated by HIV infection, the side effects of long-term treatment for HIV, the infection itself and often, treatments for age-associated illnesses”
NIH statement on National HIV/AIDS and Aging Awareness Day Sept. 18, 2010http://www.nih.gov/news/health/sep2010/niaid-09.htm.
Barriers to HIV Managementin Older Adults
• Age as independent predictor on clinical progression on HAART
• Significantly slower CD4 cell reconstitution• Older patients are more susceptible to the
adverse events of therapy• Older patients have greater number of co-morbid
conditions• Viral suppression and adherence
Kirk JB: J Am Geriatr Soc. 2009;57:2129-2138Hinkin, CH: AIDS 2001; 15:1576-9Grabar,S: JAC; Jan 2006; 57:4-7
Time to AIDS Diagnosis After a Diagnosisof HIV Infection in 2008 (40 States)
< 20 (n=2246) 20 to 34 (n=16,557)
35 to 49 (n=16,287)
> 50 (n=6,894)
0
10
20
30
40
50
60
70
80
90
15.424.1
38.645.9
84.675.9
61.454.1
< 12 months (overall:32.8%)> 12 months (overall: 67.2%)
Age at HIV Diagnosis
AID
S di
agno
sis
Aft
er
Dia
gnos
is o
f HIV
Infe
ction
(%)
CDC. HIV Surveillance Report, 2009. http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/.
Survival After AIDS Diagnosis(1998-2005)
0
0.2
0.4
0.6
0.8
1
Prop
ortio
n Su
rviv
ing
0 12 24 36 48 60 72 84 96 108
Months After AIDS Diagnosis
<1313-2425-3435-4445-54
>55
Age atTime of
Diagnosis
CDC. HIV Surveillance Report, 2009. Available at: http://www.cdc.gov/hiv/surveillance/resources/reports/2009report/.
Factors of and Obstacles to Successful Aging With HIV
Vance DE, et al. Clin Interv Aging. 2011;6:181-192
Successful Aging
• Length of life– Number of years one remains alive– Decreased compared to general population– Lower in men, IVDU, lower initial CD4 count
• Biological Health– How well is the interaction and function of
the different systems of the body– Compromise of the immune system– Bacterial translocation and alcohol
Vance DE, et al. Clin Interv Aging. 2011;6:181-192
Successful Aging
• Cognitive efficiency– Optimal neurological integrity– Cognitive decline versus same-aged peers– Substance use
• Mental Health– Emotional equilibrium– HIV and poor mental health– HIV and stigma– Coping with HIV while aging
Vance DE, et al. Clin Interv Aging. 2011;6:181-192
Aging in HIV Infection
• Chronic inflammatory stimulation• Bone fractures/Osteoporosis/Osteopenia• Increase in cardiovascular disease• Increased rates of non-AIDS associated
malignancies• Faster neurocognitive decline• Functional decline
Polypharmacy in Older HIV-Infected PatientsVariables Total Age Group P Value
< 50 50-64 >65
Non-ART medication, n (%)
Antihypertensives (not ACE inhibitors)
785 (9.7) 300 (5.4) 341 (15.9) 144 (33.4) <0.001
Antihypertensives(ACE inhibitors)
874 (10.7) 311 (5.6) 415 (19.3) 148 (34.3) <0.001
Lipid-lowering agents 1013 (12.4) 324 (5.8) 511 (23.8) 178 (41.3) <0.001
Oral antidiabetics 170 (2.1) 49 (0.9) 82 (3.8) 39 (9.1) <0.001
Insulin 118 (1.5) 39 (0.7) 52 (2.4) 27 (6.3) <0.001
Antiplatelets drugs 473 (5.8) 110 (2.0) 233 (10.8) 130 (30.2) <0.001
Antidepressants 792 (9.7) 514 (9.3) 240 (11.2) 38 (8.8) 0.140
Hasse B, et al. 18th CROI; 2011; Boston, MA. Abstract 792
Inflammation and Aging: Therapeutic Strategies
• Reduce inflammation– Residual HIV replication (ART intensification?)– Prednisone, HU, cyclosporine, mycophenolic acid– Chronic/persistent co-infections (HCV, CMV)– Microbial translocation (sevelamer, colostrum)– CCR5 inhibitors– Chloroquine (reduced PDC mediated IFNα)– NSAIDs (COX-2 inhibitors)
Inflammation and Aging: Therapeutic Strategies
• Enhance T-cell renewal– GH, IL-7, stem cell transplant, perfenidone,
leuprolide (Lupron®)
• Anti-aging interventions– Caloric restrictions– Sirtuin activators, Telomerase activators– Vitamin D, omega-3 fatty acids, sirolimus
(Rapamycin®)
Treating HIV Does Not Fully restore Life expectancy
Losina et al. CID 2009
T cell activation in human immunodeficiency virus (HIV)-infected and HIV-uninfected adults
Hunt P W et al. J Infect Dis. 2003;187:1534-1543© 2003 by the Infectious Diseases Society of America
Comorbidities Associated With Aging and HIV Infection
Hypertension Diabetes Vascular disease
Pulmonary disease
Renal Disease05
101520253035404550
40-49 Years 50-59 Years > 60 Years
Perc
ent o
f Pre
vale
nce
Goulet JL, et al. Clin Infect Dis. 2007;45:1593-1601
Diabetes Mellitus in HIV and Aging
• Incidence is higher in HIV-infected patients• Most important prevention is to avoid
excess weight gain.• It could be related to the use of certain
antiretrovirals• Screening for glucose intolerance should
be performed regularly
Summary Report from the HIV and Aging Consensus Project
JAGS 60:974-979, May2012
Cardiovascular Disease in HIV and Aging
• HIV-infected patients have greater 10-year risk of cardiovascular disease
• Higher rates of atherosclerosis independent of viral load, ARV or extent of immunodeficiency (SMART)
• Smoking• Dyslipidemia and metabolic syndrome• Overweight
Brooks et al. Am J Public Health 2012;102:1516-1526
Pathogenesis of CV Disease in HIV
HIV cART HIV
InsulinResistance
Lipodystrophy InflammationDyslipidemia
DiabetesMellitus
CVDEndothelial dysfunction
van Wijk at al. Int J Vasc Med. 2012; ID201027
Risk Factors Contributing to Development of Kidney Disease
Modifiable risk factors• Diabetes mellitus• High blood pressure• Kidney stones• Inflammation (eg GMN)• Allergic reaction to med
(eg, antibiotics)• Medications (eg, NSAIDs)• Drug abuse• Use of creatine, hGH
testosterone
Non-modifiable risk factors• Age• Family history of kidney
disease• Trauma or accident• Presence of other
diseases:– HIV/AIDS, hepatitis C, lupus,
sickle cell anemia, cancer, congestive heart failure
http://www.kidney.org/professionals/KDOQI/guidelines_ckd/p7_risk_g13.htm
HIV and Age as Renal Risk Factor
• Among 2159 HIV-infected patients enrolled in ACTG studies• 30% of patients had low baseline glomerular
filtration rate (GFR)• Median age was significantly higher in
patients with low versus normal GFR• 42 versus 36 years, respectively; P<.0011
Kalayjian R. 14th CROI. 2007. Abstract 827.
HIV and Age as Renal Risk Factor
• In the EuroSIDA cohort, the rate of chronic renal failure at baseline ranged from 3.5% to 4.7% depending on the method of GFR calculation• By multivariate analysis, age was a strong
predictor of chronic renal failure at baseline• OR 5.47, 95% CI 4.4-6.72; P<.00012
Mocroft A. AIDS. 2007;21(9):1119-1127.
Bone Health in HIV and Aging
• Among HIV-infected adults up to 60% have osteopenia, and up to 15% osteoporosis
• Higher rates of fragility fractures• Rates of fracture 60% greater on those
with nadir CD4 < 200• BMD assessment
Triant VA. J Clin Endocrinol Metab 2008:93(9):3499-3504
Sharma A. AIDS. 2010;24(15):2337-2345
BMD is Lower in HIV-Infected Women > 40 Years of Age
Femur neck and lumbar spine
Femoral neck only Lumbar Spine only0
5
10
15
20
25
3027
12
2119
7
15
HIV InfectedControl
Perc
ent W
ith L
ow B
MD
Arnsten JH, et al. Clin Infect Dis. 2006;42:1014-1020
BMD is Lower in HIV-Infected Older Men
Femoral Neck Total Hip Lumbar Spine0
0.2
0.4
0.6
0.8
1
1.2
1.4 HIV infected (n=230)Control (n=159)
BMD
at F
irst
DEX
A (g
/cm
2)
Sharma A et al. AIDS. 2010, 24:2337-2345Osteopenia incidence per 100 person-years at risk was 2.6 for HIV-uninfectedMen and 7.2 for HIV-infected men
Frailty in HIV and Aging
• Weakness• Low physical activity• Slow motor performance• Weight loss• Weak grip strength• Factors associated with frailty: higher
depression score, unemployment, greater comorbid conditions, past OIs
Brooks et al. Am J Public Health.2012;102:1516-1526
Psychiatric and Neurocognitive Disorders
• Alcohol and drug use• Thought and mood disorders• Depression and suicide• Decrease memory
• UPDRS motor scores were 40.7% in HIV infected vs 15.7% in HIV-– Slowness of hand movement, body bradykinesia,
tremor
Valcour V at al. J Neurovirol. 2008;14:362-367Vance et al. Clin Interv Aging 2011:6 181-192
Neurocognitive Complications in HIV
42%
53%
5%
Asymptomatic Neurocognitive Impairment (ANI)
Mild Neurocognitive Disorder (MND)
HIV-associated Dementia (HAD)
Valcour V, et al. CROI 2012. Abstract 498
Cancer in HIV and AgingPatel P. Ann Intern Med. 2008;148(10):728-736
• Higher incidence among HIV-infected– Anal– Vaginal– Hodgkin’s lymphoma– Liver– Lung– Melanoma– Oropharyngeal– Leukemia– Colorectal– Renal
Higher Cancer Risk in HIV infection
• Kaposi’s sarcoma 199-fold• Non-Hodgkin lymphoma 15-fold• Anal cancer 55-fold• Hodgkin lymphoma 19-fold• Melanoma 1.8-fold• Liver cancer 1.8-fold
Silverberg MJ. CEBP. Dec2011 20:2551-2559
Cancer Screening
• Cervical cancer• Colon cancer• Anal cancer• Liver cancer• Skin cancer• Cancer screening should be in
accordance with current guidelines for the general population
Cancer Screening
• Cervical cancer– PAP smear upon starting care and again in
six months– If abnormal: Colposcopy and biopsy
• Anal cancer– RR increases 37-fold among HIV+ men– RR increased 60-fold among HIV+ MSM
USPSTF, CDC, HIVMA Recommendations
Aberg JA et al. CID 2004 39(5)609-29
Frisch M et al. J NCI 2000 92(18)1500-10
Colorectal Cancer Screening
Series10
10
20
30
40
50
60
70
80
90
43
5.3 2.6
17.2
55.649.3
66.6
17.5
7.9
27.5
77.8
65.6
HIV +HIV -
Prop
ortio
n Te
sted
(%)
Fecal OccultBlood Test
Reinhold JP et al. Am J Gastroenterol. 2005;100:1805-1812
FlexibleSigmoidoscopy
Air ContrastBarium Enema
Colonoscopy At least 1 CRCScreening Test
UTD with at least 1CRC Screening TestPerformed
Summary• HIV population is aging• Providers should ask all patients about high-
risk behaviors and educate them on the risks
• Management of older HIV-infected patients may be complicated by comorbidities
• Comorbidities attributed to increasing age may overlap with morbidity from HIV disease and toxicity from ART
Summary• Current ARV therapies are effective in reducing
progression of the disease and mortality• Life expectancy is shorter than normal despite
optimal ART. – It appears to be predicted by lower CD4 and higher
inflammation.
• Markers of inflammation and T cell activation remain higher in ART than non-HIV infected
• Early diagnosis, and probably early therapy initiation, may improve outcomes in this population